Tweet This is one for the newspapers no doubt, so Ready Meals are a risk factor for MS. Does the “salt idea” (causes MS) come back to the table. A few years ago the Great and the Good told us that the MacDonuts culture (Salt…
More than 70% of people with multiple sclerosis (MS) receiving outpatient rehabilitation take at least five medications — often including vitamin supplements and drugs used to manage symptoms such as muscle stiffness, pain, and mental health issues — to treat their MS. That’s according to…
A new study being funded by the National Multiple Sclerosis Society (NMSS) will seek to better understand how women with multiple sclerosis (MS) navigate menopause and develop resources to address gaps in care. The study, “The Menopausal Transition, MS Symptom Management, and Multidisciplinary Care Gaps,” will…
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth,…
Tweet Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. Gold R, Selmaj KW, Berkovich R, Cohen JA, Comi G, Havrdová EK, Sheffield JK, Desai H, Cheng CY, Riolo JV, Thorpe A, DeBoer E, Cree BAC.Ann Clin Transl Neurol. 2026 Mar 27. doi: 10.1002/acn3.70366. Online…
Quantum Biopharma is preparing to seek permission in the U.S. to launch its planned clinical trial of Lucid-MS, an oral therapy that aims to slow myelin loss — which ultimately results in the neurological problems that drive multiple sclerosis (MS) — in people with the…
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…
Tweet Zanghì A, Spelman T, Fabis-Pedrini M, Carroll WM, Butzkueven H, Kermode AG, Lechner-Scott J, van der Walt A, D’Amico E. Ocrelizumab Discontinuation vs. Continuation After Safety Events: Comparative Insights from MSBase. Curr Neuropharmacol. 2026 Mar 24. doi: 10.2174/011570159X448901251228053318. Introduction: Ocrelizumab (OCR), a CD20+ B-cell…
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…